GXMC
CLVS

Global X Management Company’s Clovis Oncology, Inc. CLVS Stock Holding History

Global X Management Company’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$28K Buy
617
+48
+8% +$2.33K ﹤0.01% 1164
2018
Q1 		$30K Buy
569
+144
+34% +$8.4K ﹤0.01% 1084
2017
Q4 		$29K Buy
425
+97
+30% +$6.78K ﹤0.01% 999
2017
Q3 		$27K Buy
328
+47
+17% +$3.73K ﹤0.01% 1013
2017
Q2 		$26K Buy
+281
New +$17.2K ﹤0.01% 1090

Other funds holding CLVS

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

Global X Management Company's CLVS Position: Q2 2018 in Review

Global X Management Company increased its Clovis Oncology, Inc. (CLVS) stake by 8.4% in Q2 2018, buying an estimated $2.33K and bringing the position to 617 shares worth $28K. The position accounts for ﹤0.01% of the portfolio, ranked #1164.

Global X Management Company first reported a position in CLVS in Q2 2017 and has held it in 5 quarters since. The position peaked at $30K in Q1 2018. 210 funds tracked by Wall St. Rank hold CLVS as of Q2 2018.

  • Global X Management Company held 617 shares of Clovis Oncology, Inc. worth $28K as of Q2 2018.
  • Global X Management Company bought 48 Clovis Oncology, Inc. shares in Q2 2018, an estimated $2.33K.
  • Clovis Oncology, Inc. made up ﹤0.01% of Global X Management Company's portfolio in Q2 2018, its #1164 holding.
  • Global X Management Company first reported a position in Clovis Oncology, Inc. in Q2 2017 and has held it in 5 quarters since.
  • Global X Management Company's Clovis Oncology, Inc. position peaked at $30K in Q1 2018.
  • 210 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2018.

Based on Global X Management Company's 13F filing for Q2 2018, filed 16 Aug 2018.